ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MDT Medtronic PLC

84.72
0.00 (0.00%)
Pre Market
Last Updated: 12:31:29
Delayed by 15 minutes
Share Name Share Symbol Market Type
Medtronic PLC NYSE:MDT NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 84.72 33 12:31:29

HEARTWARE (HTWR) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sa...

27/06/2016 1:31pm

PR Newswire (US)


Medtronic (NYSE:MDT)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Medtronic Charts.

SAN DIEGO, June 27, 2016 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of HeartWare International, Inc. (NASDAQ: HTWR) breached their fiduciary duties in connection with the proposed sale of the Company to Medtronic plc (NYSE: MDT).

Johnson & Weaver LLP (PRNewsFoto/Johnson & Weaver LLP)

Additional Information:
HeartWare designs, develops, manufactures and markets miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure.

On June 27, 2016, HeartWare announced it had signed a definitive merger agreement with Medtronic. Under the terms of the agreement, HeartWare stockholders will receive $58.00 per share in cash. The proposed transaction is subject to regulatory approval.

The investigation concerns whether the HeartWare board failed to satisfy their duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for HeartWare shares of common stock. Nationally recognized Johnson & Weaver is investigating whether the proposed deal price represents adequate consideration; especially given that the price target for one Wall Street analyst is $60.00. The 52-week high for HeartWare stock is $94.15.

If you are a shareholder of HeartWare and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (jimb@johnsonandweaver.com) at 619-814-4471. If emailing, please include a phone number where you can be reached.

About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com

Logo - http://photos.prnewswire.com/prnh/20160211/332409LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/heartware-htwr-alert-johnson--weaver-llp-launches-an-investigation-into-the-fairness-of-price-and-process-in-proposed-sale-of-heartware-international-inc-are-shareholders-getting-a-fair-price-300290447.html

SOURCE Johnson & Weaver, LLP

Copyright 2016 PR Newswire

1 Year Medtronic Chart

1 Year Medtronic Chart

1 Month Medtronic Chart

1 Month Medtronic Chart

Your Recent History

Delayed Upgrade Clock